Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
L&C BIO financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
₩18.4 K
2024-10-29
Market Capitalization
₩407.2 B
2024-10-29
Revenue
₩72.1 B
FY, 2024
CreditSafe Score
?
Score changed on Jun 06, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| KRW | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 21.2B | 29.2B | 33.0B | 45.7B | 52.6B | 68.9B | 72.1B |
| Cost of goods sold | 6.5B | 8.1B | 7.9B | 12.7B | 18.6B | 30.7B | 32.0B |
| Gross profit | 14.8B | 21.2B | 25.7B | 33.3B | 34.8B | 41.3B | 40.4B |
| Gross profit margin, % | 72.7% | 77.8% | 72.9% | 66.2% | 60.0% | 56.0% | |
| Operating expense total | 8.8B | 10.9B | 16.2B | 16.9B | 20.0B | 24.8B | 30.8B |
| Depreciation and amortization | 481.8M | 1.1B | 1.6B | 2.9B | 4.5B | 8.1B | 6.8B |
| EBITDA | 6.0B | 10.2B | 14.9B | 20.1B | 14.0B | 76.9B | 157.6B |
| EBITDA margin, % | 35.1% | 45.1% | 44.1% | 26.6% | 111.6% | 218.5% | |
| EBIT | 4.7B | 9.1B | 12.9B | 17.2B | 7.2B | 67.2B | 150.6B |
| EBIT margin, % | 31.1% | 39.0% | 37.7% | 13.6% | 97.6% | 208.9% | |
| Interest income | 227.1M | 913.7M | 609.7M | 774.2M | 562.5M | 1.5B | 1.6B |
| Interest expense | 18.0M | 60.6M | 743.2M | 937.1M | 3.1B | 6.2B | 3.2B |
| Pre tax profit | 5.1B | 9.9B | 12.9B | 17.1B | 4.6B | 62.9B | 137.8B |
| Income tax expense | 1.5B | 795.5M | 1.5B | (1.1B) | 16.8B | (5.4B) | |
| Net Income | 5.1B | 8.5B | 12.1B | 15.6B | 5.7B | 46.1B | 143.2B |